New Study: Swift Blood Sugar Control Cuts Heart Attack Risk in Type 2 Diabetes by 20%
A groundbreaking study published in Diabetes Care has revealed the critical impact of blood glucose control on heart attack risk and mortality in type 2 diabetes patients. Researchers from University Hospital Tübingen, Helmholtz Munich, and the German Center for Diabetes Research (DZD) conducted the research, which was based on the UK Prospective Diabetes Study (UKPDS).
The study underscores the importance of swift blood-sugar control for people with type 2 diabetes. Early detection and treatment are crucial to prevent long-term complications and mortality. A joint study by the Universities of Gothenburg and Oxford found that blood-sugar levels immediately after diagnosis significantly influence long-term prognosis.
Targeting blood-sugar levels according to guidelines (HbA1c 52 mmol/mol or lower) from the time of diagnosis can reduce the risk of death by approximately 20% within 10-15 years. Conversely, delaying good blood-sugar control until 10 years after diagnosis results in only a 3% reduction in death risk.
The findings emphasize the urgent need for type 2 diabetes patients to manage their blood-sugar levels effectively from the moment of diagnosis. This can significantly improve long-term prognosis and reduce the risk of heart attacks and mortality.
